Zhengye Biotechnology Holding Limited Ordinary Shares Market Cap ($54.50 Million)
Market Cap & Net Worth: Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT)
Zhengye Biotechnology Holding Limited Ordinary Shares market cap. Zhengye Biotechnology Holding Limited Ordinary Shares (NASDAQ:ZYBT) has a market capitalization of $54.50 Million ($54.50 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #21365 globally and #4797 in its home market, demonstrating a -5.63% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhengye Biotechnology Holding Limited Ordinary Shares's stock price $1.34 by its total outstanding shares 47391376 (47.39 Million). Also see Zhengye Biotechnology Holding Limited Or cash conversion from operations for how efficiently the company converts equity into cash flow.
Zhengye Biotechnology Holding Limited Ordinary Shares Market Cap History (2025–2026)
Zhengye Biotechnology Holding Limited Ordinary Shares market cap history from 2025 to 2026. Data shows change from $54.50 Million to $63.50 Million (-48.62% CAGR). Check Zhengye Biotechnology Holding Limited Or stock price for real-time trading data and today's change.
Index Memberships
Zhengye Biotechnology Holding Limited Ordinary Shares is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #608 of 976 |
Weight: Zhengye Biotechnology Holding Limited Ordinary Shares's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Zhengye Biotechnology Holding Limited Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhengye Biotechnology Holding Limited Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Zhengye Biotechnology Holding Limited Or equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.29x
Zhengye Biotechnology Holding Limited Ordinary Shares's market cap is 0.29 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.82x
Zhengye Biotechnology Holding Limited Ordinary Shares's market cap is 4.82 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $54.50 Million | $186.36 Million | $11.31 Million | 0.29x | 4.82x |
Competitor Companies of ZYBT by Market Capitalization
Companies near Zhengye Biotechnology Holding Limited Ordinary Shares in the global market cap rankings as of November 4, 2026. Also see ZYBT total asset value for a full breakdown of the balance sheet.
Key companies related to Zhengye Biotechnology Holding Limited Ordinary Shares by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Zhengye Biotechnology Holding Limited Ordinary Shares (2025–2026)
Market capitalization of Zhengye Biotechnology Holding Limited Ordinary Shares from 2025 to today. Between 2025 and today, Zhengye Biotechnology Holding Limited Ordinary Shares's market cap moved from $54.50 Million to $ 63.50 Million, with a yearly change of -48.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $63.50 Million | +16.52% |
| 2025 | $54.50 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Zhengye Biotechnology Holding Limited Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $54.50 Million USD |
| MoneyControl | $54.50 Million USD |
| MarketWatch | $54.50 Million USD |
| marketcap.company | $54.50 Million USD |
| Reuters | $54.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zhengye Biotechnology Holding Limited Ordinary Shares
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for househol… Read more